Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis

Abstract

In high risk individuals, a reduced CPC count helps identifying more patients at higher risk of MACE over the short term, especially in combination with a raised hsCRP level.